Loading clinical trials...
Loading clinical trials...
An Open-Label Extension (OLE) Study to Evaluate the Safety of the ForSight VISION5 Product in Subjects With Open-Angle Glaucoma or Ocular Hypertension Who Have Completed Study FSV5-002
Conditions
Interventions
Bimatoprost
Locations
10
United States
Sall Medical Research Center
Artesia, California, United States
Scripps Clinic Torrey Pines
La Jolla, California, United States
Eye Research Foundation
Newport Beach, California, United States
UC Davis Dept of Ophthalmology & Vision Science
Sacramento, California, United States
Coastal Research Associates
Atlanta, Georgia, United States
Clayton Eye Center
Morrow, Georgia, United States
Start Date
June 5, 2014
Primary Completion Date
December 31, 2015
Completion Date
January 31, 2016
Last Updated
February 26, 2019
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT07076303
NCT06865144
Lead Sponsor
ForSight Vision5, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions